FDA.reportPublic FDA data

Dr.eslee Intensive Recovery Blemish Balm

Manufacturer
Ajou Medics Co., Ltd | Ajou Medics Co., Ltd.
Effective date
2018-01-17
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-02 01:04:51

Label at a glance#

ProductDr.eslee Intensive Recovery Blemish Balm
Active ingredientZINC OXIDE
Label structure8 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

zinc oxide


INACTIVE INGREDIENT SECTION

Water, Titanium Dioxide, Ethylhexyl Methoxycinnamate, Butylene Glycol, Hexyl Laurate, Caprylic/Capric Triglyceride, Cetyl Ethylhexanoate, Talc, Dipropylene Glycol, Dimethicone, Phenyl Trimethicone, Isoamyl p-Methoxycinnamate, Arbutin, Cetyl PEG/PPG-10/1 Dimethicone, Pentylene Glycol, 1,2-Hexanediol, Palmitoyl Pentapeptide-4, Copper Tripeptide-1, rh-Oligopeptide-1, Zinc Oxide, Magnesium Sulfate, Polyglyceryl-3 Diisostearate, Simmondsia Chinensis (Jojoba) Seed Oil, Sorbitan Olivate, Sorbitan Sesquioleate, Beeswax, Macadamia Ternifolia Seed Oil, Cyclopentasiloxane, Iron Oxides (CI 77492), Disteardimonium Hectorite, Aluminum Hydroxide, Iron Oxides (CI 77491), Triethoxycaprylylsilane, Iron Oxides (CI 77499), Tocopheryl Acetate, C30-45 Alkyl Cetearyl Dimethicone Crosspolymer, Panthenol, Allantoin, Niacinamide, Adenosine, Bisabolol, Polysorbate 20, Aloe Barbadensis Leaf Juice, Centella Asiatica Extract, Snail Secretion Filtrate, Carbomer, Glycerin


OTC - PURPOSE SECTION

helps to protect from UV-Raysskin whitening and wrinkle removing


OTC - KEEP OUT OF REACH OF CHILDREN SECTION

keep out of reach of the children


INDICATIONS & USAGE SECTION

Apply Proper Amount of the cream on skin



WARNINGS SECTION

■ For external use only.
■ Avoid contact with eyes.
■ Do not swallow. If swallowed, get medical help.
■ Keep out of reach of children.
■ Stop use and ask doctor if rash and irritation develops.


DOSAGE & ADMINISTRATION SECTION

for topical use only


PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

package insert
package insert

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
76340-1301-12022-06-26C16284748780-1d6a99b39-9caf-a426-e053-dadaa90af4c2Drug Facts
76340-1301-12022-01-28C16284748780-1d6a99b39-9caf-a426-e053-dadaa90af4c2Drug Facts

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
Zinc oxideACTIVE INGREDIENTSOI2LOH54Z1
Zinc oxideACTIVE MOIETYSOI2LOH54Z1
BUTYLENE GLYCOLINACTIVE INGREDIENT3XUS85K0RA1
DIMETHICONEINACTIVE INGREDIENT92RU3N3Y1O1
OCTINOXATEINACTIVE INGREDIENT4Y5P7MUD511

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
76340-130176340-1301-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Name, UNII, Kind table
NameUNIIKind
OCTINOXATE4Y5P7MUD51IACT
BUTYLENE GLYCOL3XUS85K0RAIACT
DIMETHICONE92RU3N3Y1OIACT
ZINC OXIDESOI2LOH54ZACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 2 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
BUTYLENE GLYCOLBUTYLENE GLYCOL3XUS85K0RASYSTEM / TOPICAL1400 mgExact identifier — unii candidate
2 equally ranked IID candidates
BUTYLENE GLYCOLBUTYLENE GLYCOL3XUS85K0RASYSTEM / TRANSDERMAL8.12 mgExact identifier — unii candidate
2 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
e252cf6c-71c4-5d66-e053-2a95a90aaf6475ab1c72-c4a6-4a8d-a976-e7c6ca46a6372022-06-25WarningsExact identifier
spl set id: 75ab1c72-c4a6-4a8d-a976-e7c6ca46a637

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.